References

A decade of organoid research: progress and challenges in the field of organoid technology

10.1021/acsomega.4c03683 · 2024 · External reference

Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation

10.1038/s41598-017-07014-0 · 2017 · External reference

Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis

10.1096/fj.201802805rr · 2019 · External reference

Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO), international osteoporosis foundation (IOF), and international Federation of clinical chemistry and laboratory medicine (IFCC)

10.1007/s00198-025-07422-3 · 2025 · External reference

Estrogen deficiency alters vascularization and mineralization dynamics: insight from a novel 3-D humanized and vascularized bone organoid model

10.1152/ajpcell.00738.2024 · 2025 · External reference

Organ-on-a-chip: current gaps and future directions

10.1042/bst20200661 · 2022 · External reference

Roles of Wnt/β-Catenin signaling in osteoporosis, disease pathogenesis, and natural compound intervention

10.4062/biomolther.2025.126 · 2026 · External reference

Mechanosignaling in osteoporosis: when cells feel the force

10.3390/ijms26094007 · 2025 · External reference

Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover

10.3390/ijms23031376 · 2022 · External reference

The epidemiology of osteoporosis

10.1093/bmb/ldaa005 · 2020 · External reference

Engineering osteoclast resorption units via sacrificial microgels in a bone-on-chip platform

10.1039/d5lc00682a · 2026 · External reference

Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024

10.1093/jbmr/zjae119 · 2024 · External reference

Loop between NLRP3 inflammasome and reactive oxygen species

10.1089/ars.2020.8257 · 2022 · External reference

Preservation of extracellular matrix in decellularized bone scaffolds: strategies, challenges, and future directions

10.1016/j.tice.2025.103047 · 2025 · External reference

A detailed methodology for a three-dimensional, self-structuring bone model that supports the differentiation of osteoblasts towards osteocytes and the production of a complex collagen-rich mineralised matrix

10.12688/f1000research.130779.3 · 2023 · External reference

Aged-vascular niche hinders osteogenesis of mesenchymal stem cells through paracrine repression of wnt-axis

10.1111/acel.14139 · 2024 · External reference

Osteochondral organoid biofabrication: construction strategies, applications and perspectives

10.1088/1758-5090/ade740 · 2025 · External reference

RANKL (receptor activator of NFκB ligand) produced by osteocytes is required for the increase in B cells and bone loss caused by estrogen deficiency in mice

10.1074/jbc.m116.742452 · 2016 · External reference

3D bioprinting bone/cartilage organoids: construction, applications, and challenges

10.1016/j.jot.2025.08.008 · 2025 · External reference

Toxic or not toxic? The specifications of the standard ISO 10993-5 are not explicit enough to yield comparable results in the cytotoxicity assessment of an identical medical device

10.3389/fmedt.2023.1195529 · 2023 · External reference

Dual 3D printing for vascularized bone tissue regeneration

10.1016/j.actbio.2021.01.012 · 2021 · External reference

Three-dimensionally cultured jaw periosteal cells attenuate macrophage activation of CD4(+) T cells and inhibit osteoclastogenesis

10.3390/ijms25042355 · 2024 · External reference

In-silico analysis predicts disruption of normal angiogenesis as a causative factor in osteoporosis pathogenesis

10.1186/s12863-024-01269-z · 2024 · External reference

Organoids are not organs: sources of variation and misinformation in organoid biology

10.1016/j.stemcr.2023.05.009 · 2023 · External reference

Bone-on-a-Chip: biomimetic models based on microfluidic technologies for biomedical applications

10.1021/acsbiomaterials.3c00066 · 2023 · External reference

Bone formation is coupled to resorption Via suppression of sclerostin expression by osteoclasts

10.1002/jbmr.3175 · 2017 · External reference

Advance in the application of organoids in bone diseases

10.3389/fcell.2024.1459891 · 2024 · External reference

Bone-on-a-chip simulating bone metastasis in osteoporosis

10.1088/1758-5090/ad6cf9 · 2024 · External reference

Sclerostin binds to LRP5/6 and antagonizes canonical wnt signaling

10.1074/jbc.m413274200 · 2005 · External reference

Dkk1-mediated inhibition of wnt signaling in bone results in osteopenia

10.1016/j.bone.2006.03.017 · 2006 · External reference

Vascularization of a bone organoid using dental pulp stem cells

10.1155/2023/5367887 · 2023 · External reference

Bone organoids as advanced models for osteoporosis: development, application, and future prospects

10.3390/ijms27073118 · 2026 · External reference

Innovative strategies for bone organoid: synergistic application and exploration of advanced technologies

10.1016/j.jot.2025.07.010 · 2025 · External reference

Osteoimmunology: crosstalk between T cells and osteoclasts in osteoporosis

10.1007/s12016-025-09046-1 · 2025 · External reference

ISSCR standards for the use of human stem cells in basic research

10.1016/j.stemcr.2023.08.003 · 2023 · External reference

Printability and cell viability in extrusion-based bioprinting from experimental, computational, and machine learning views

10.3390/jfb13020040 · 2022 · External reference

Role of wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders

10.1007/s00198-022-06523-7 · 2023 · External reference

The role of reactive oxygen species in bone cell physiology and pathophysiology

10.1016/j.bonr.2023.101664 · 2023 · External reference

A novel 3D osteoblast and osteocyte model revealing changes in mineralization and pro-osteoclastogenic paracrine signaling during estrogen deficiency

10.3389/fbioe.2020.00601 · 2020 · External reference

3D extracellular matrix mimics: fundamental concepts and role of materials chemistry to influence stem cell fate

10.1021/acs.biomac.0c00045 · 2020 · External reference

Collagen/hydroxyapatite hydrogels promote intercellular interactions and osteogenic differentiation

10.1002/jbm.b.35632 · 2025 · External reference

Effect of T cells on bone

10.1016/j.bone.2023.116675 · 2023 · External reference

Biomarker discovery and validation: statistical considerations

10.1016/j.jtho.2021.01.1616 · 2021 · External reference

Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility

10.1016/j.stemcr.2024.03.009 · 2024 · External reference

Revolutionizing immune research with organoid-based co-culture and chip systems

10.1093/cei/uxae004 · 2024 · External reference

Trabecular bone organoid model for studying the regulation of localized bone remodeling

10.1126/sciadv.abd6495 · 2021 · External reference

Pathophysiology of bone remodelling cycle: role of immune system and lipids

10.1016/j.bcp.2025.116844 · 2025 · External reference

Type H blood vessels in bone modeling and remodeling

10.7150/thno.34126 · 2020 · External reference

Modelling osteoporosis in pre-clinical research-challenges, trends and new approaches

10.3390/cells14211649 · 2025 · External reference

Functional roles of immune cells in osteoporosis

10.3389/fimmu.2025.1698283 · 2025 · External reference

Molecular mechanosensors in osteocytes

10.1038/s41413-020-0099-y · 2020 · External reference

Structure and functions of blood vessels and vascular niches in bone

10.1155/2017/5046953 · 2017 · External reference

Blood flow controls bone vascular function and osteogenesis

10.1038/ncomms13601 · 2016 · External reference

Principles of indirect Co-culture method using transwell

10.1007/7651_2024_537 · 2025 · External reference

Microengineered bone models: advances and applications of bone-on-a-chip technology

10.1186/s13036-026-00703-3 · 2026 · External reference

Measuring mineralised tissue formation and resorption in a human 3D osteoblast-osteoclast co-culture model

10.22203/ecm.v040a12 · 2020 · External reference

Development of a microfluidic vascularized osteochondral model as a drug testing platform for osteoarthritis

10.1002/adhm.202402350 · 2024 · External reference

3D in vitro models of the bone marrow niche

10.1021/acsbiomaterials.5c01421 · 2026 · External reference

The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019

10.3389/fendo.2022.882241 · 2022 · External reference

MicroRNAs in serum exosomes as circulating biomarkers for postmenopausal osteoporosis

10.3389/fendo.2022.819056 · 2022 · External reference

A comparison of osteoblast and osteoclast in vitro Co-Culture models and their translation for preclinical drug testing applications

10.3390/ijms21030912 · 2020 · External reference

Advances in pathogenesis and therapeutic strategies for osteoporosis

10.1016/j.pharmthera.2022.108168 · 2022 · External reference

Inhibitors of the wnt pathway in osteoporosis: a review of mechanisms of action and potential as therapeutic targets

10.17305/bb.2024.11200 · 2025 · External reference

A 3D human bone and bone Marrow-on-a-Chip model for in vitro bone remodeling and immune cell maintenance

10.1002/advs.202518224 · 2026 · External reference

Vascularized tissue organoids

10.3390/bioengineering10020124 · 2023 · External reference

Synergistic promotion of bone regeneration through co-culture of endothelial cells with mesenchymal stem cells in endochondral ossification organoids

10.1186/s13287-025-04733-4 · 2025 · External reference

Inflammatory processes affecting bone health and repair

10.1007/s11914-023-00824-4 · 2023 · External reference

Molecular mechanisms involved in hypoxia-induced alterations in bone remodeling

10.3390/ijms23063233 · 2022 · External reference

A protocol for modeling human bone inflammation: co-culture of osteoblasts and osteoclasts exposed to different inflammatory microenvironments

10.3390/mps8050097 · 2025 · External reference

Practical considerations for the clinical application of bone turnover markers in osteoporosis

10.1007/s00223-021-00930-4 · 2023 · External reference

Osteoclasts, master sculptors of bone

10.1146/annurev-pathmechdis-031521-040919 · 2023 · External reference

Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods

10.1007/s00198-019-04892-0 · 2019 · External reference

Mechanical regulation of bone remodeling

10.1038/s41413-022-00190-4 · External reference

Insights into the role of macrophage polarization in the pathogenesis of osteoporosis

10.1155/2022/2485959 · External reference

Engineering large-scale self-mineralizing bone organoids with bone matrix-inspired hydroxyapatite hybrid bioinks

10.1002/adma.202309875 · 2024 · External reference

Integrated single-cell RNA-Seq and bulk RNA-Seq identify diagnostic biomarkers for postmenopausal osteoporosis

10.2174/0109298673343344240930054414 · External reference

Standardization and consensus in the development and application of bone organoids

10.7150/thno.105840 · External reference

Emerging applications of feature selection in osteoporosis research: from biomarker discovery to clinical decision support

10.1093/jbmr/zjaf105 · External reference

Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-Dependent pathway

10.1371/journal.pone.0025900 · 2011 · External reference

Osteocytes: master orchestrators of skeletal homeostasis, remodeling, and osteoporosis pathogenesis

10.3389/fcell.2025.1670716 · 2025 · External reference

A review on cell damage, viability, and functionality during 3D bioprinting

10.1186/s40779-022-00429-5 · 2022 · External reference

From niche to organoid: engineering bone tissues through microenvironmental insights

10.1177/20417314251358567 · 2025 · External reference

Contribution of macrophage polarization in bone metabolism: a literature review

10.1016/j.cyto.2024.156768 · 2024 · External reference

Single-cell RNA sequencing reveals multiple immune cell subpopulations promote the formation of abnormal bone microenvironment in osteoporosis

10.1038/s41598-024-80993-z · 2024 · External reference

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

10.1002/mco2.735 · 2024 · External reference

Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis

10.1002/med.22081 · 2025 · External reference

Multi-modal molecular determinants of clinically relevant osteoporosis subtypes

10.1038/s41421-024-00652-5 · 2024 · External reference

Gene expression profiles for in vitro human stem cell differentiation into osteoblasts and osteoclasts: a systematic review

10.7717/peerj.14174 · 2022 · External reference

Motivating role of type H vessels in bone regeneration

10.1111/cpr.12874 · 2020 · External reference

Long-term mechanical loading is required for the formation of 3D bioprinted functional osteocyte bone organoids

10.1088/1758-5090/ac73b9 · 2022 · External reference

Unique bone marrow blood vessels couple angiogenesis and osteogenesis in bone homeostasis and diseases

10.1111/nyas.14348 · 2020 · External reference

Organoids

10.1038/s43586-022-00174-y · 2022 · External reference

Bone organoids: recent advances and future challenges

10.1002/adhm.202302088 · 2024 · External reference

Beyond bone loss: a biology perspective on osteoporosis pathogenesis, multi-omics approaches, and interconnected mechanisms

10.3390/biomedicines13061443 · 2025 · External reference

Advances in the construction and application of Bone-on-a-Chip based on microfluidic technologies

10.1002/jbm.b.35502 · 2024 · External reference